Author: dustinprado348

Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, announced the launch of Human Leukocyte Antigen (HLA) Genotype reporting, the newest addition to the Company’s suite of comprehensive molecular science offerings. As an emerging biomarker in the treatment of cancer, HLA genes play an integral role in activating T-cells to induce an immune response and may contribute to a patient’s response to cancer immunotherapies. Caris HLA Genotype reporting builds upon the most expansive molecular intelligence available and strengthens physicians’ ability to provide more individualized treatment decisions for their patients. ... Read more